Anatara Medicine

Follow the Science: School Systems Need to Open and Stay Open The decision of whether or not to open schools and for what ages amidst the COVID-19 pandemic has been ongoing for the last several months. Concerns of increased transmission has delayed reopening schools for many areas of the world, though the CDC states there is no linked association between in-person learning in schools and substantial community transmission. Children under 17 years old, making up less than 1% ...Continue reading

Have a nice trip Dr. Ahvie Herskowitz!

Currently en route to FL to visit lovely clients, and hoping to get to one of the amazing beaches for at least an hour or two!

COVID-19 Cases Are Plummeting! There is light at the end of the tunnel! COVID-19 cases and deaths are declining, especially since February 1. In the United States, the COVID-19 fatality rate has remained a steady 1.8% since mid-December, though the average new cases per day have dropped since the beginning of February from roughly 44 in 100,000 people to 21 in 100,000 people. A similar pattern is seen in average deaths per day: 0.95 dropping to 0.62 deaths in 100,000 people.... Administration of COVID-19 vaccines began in the United States in December 2020, and roughly 77 million doses have been administered (a combination of Pfizer-BioNTech and Moderna vaccines) as of this week. With the US administering about 1.8 million shots a day, roughly 8% of the population has received both doses with a total of 15% of the population receiving at least 1 dose. The most vulnerable population of people, those 65 years old and above, make up roughly 80% of all COVID-19 deaths and only 17% of the population in the US (52.5 million people). This group accounts for only 30% of all people that received at least the first dose of a COVID-19 vaccine within the first month, yet nursing home deaths have fallen more than 60% between late December and early February. We’ve now used 77% of our total 102 million delivered doses, and we would still need to vaccinate roughly 41 million more people to fully vaccinate those over the age of 65 with two doses. If we continue to focus on vaccinating the more vulnerable populations of people, the numbers of deaths and hospitalizations will likely continue to drop, and may drop rapidly in the next month. Disclaimer: This information is formulated as my opinion, and I recommend that any individual speak with their primary doctor about their own personal health concerns and questions about COVID-19 vaccinations. Sources: https://91-divoc.com/pages/covid-visualization/ https://www.npr.org//how-is-the-covid-19-vaccination-campa https://www.worldometers.info/coronavirus/country/us/ https://www.nytimes.com//covid-variant-new-york-postal-ser. https://www.kff.org//at-this-early-stage-of-the-covid-19-/ https://www.nytimes.com//20/us/covid-19-vaccine-doses.html https://covid.cdc.gov/covid-data-tracker/ Read other COVID-19 articles and updates here: https://www.anataramedicine.com/coronavirus-main/ #coronavirus #covid19 #covid_19 #covid19_impact #ahvieherskowitz #socialdistancing #anataramedicine #covid19_lockdown #lockdown #immunology #epidemiology #prevention #drahvie #pandemic #quarantine #outbreak #openbackup #covid19_vaccine #vaccination #covid19_vaccination #covid19_autoimmunity

Single Dose Johnson & Johnson Vaccine Pending Approval Efficacy Data for FDA Approval Johnson & Johnson’s vaccine could be authorized by the FDA as early as this Saturday depending upon votes from the vaccine advisory panel tomorrow. Vaccine efficacy in the United States was 72%, and 64% in South Africa, which compares very favorably with other vaccines. The data still shows strong protection against severe COVID-19 cases and deaths, with a possible reduction of virus transmi...ssion and prevention of infection (74% effective against asymptomatic infections in small numbers of patients tested for antibodies). With the FDA’s first technical analysis this week of the Phase 3 trial, there have been no reports of severe allergic reactions like anaphylaxis, thus they claim that the Johnson & Johnson vaccine is safe with relatively mild side effects. Familiar Vaccine Technique The model of using a modified adenovirus for holding the genes to build coronavirus spike proteins is a familiar technique to vaccines: the injection of the vaccine releases the adenovirus to push the genetic instructions into the nucleus of the human cell which is copied into messenger RNA to leave the nucleus and be translated to building the coronavirus spike proteins. Distribution following FDA Approval The United States has agreed to buy 100 million doses of the Johnson & Johnson vaccine by June 2021. While Johnson & Johnson expected to produce 12 million doses by the end of February, only 2-4 million doses are estimated ready for shipment by the end of the week pending FDA authorization, and concerns over meeting their 100 million dose target by June 2021 remain. Disclaimer: This information is formulated as my opinion, and I recommend that any individual speak with their primary doctor about their own personal health concerns and questions about COVID-19 vaccinations. Sources: https://www.nytimes.com//johnson-johnson-vaccine-update.ht https://www.nytimes.com//johnson-johnson-covid-19-vaccine. Read other COVID-19 articles and updates here: https://www.anataramedicine.com/coronavirus-main/ #coronavirus #covid19 #covid_19 #covid19_impact #ahvieherskowitz #socialdistancing #anataramedicine #covid19_lockdown #lockdown #immunology #epidemiology #prevention #drahvie #pandemic #quarantine #outbreak #openbackup #covid19_vaccine #vaccination #covid19_vaccination #covid19_autoimmunity